Highlights
NASDAQ: DUSA       Davis Select USA ETF
Last Price Today's Change   Day's Range   Trading Volume
18.481   -0.968 (4.98%)  18.42 - 18.831  150,000

Overview

 
Avg Volume (4 weeks):58,342
4 Weeks Range:16.921 - 24.735
4 Weeks Price Volatility (%):
19.96%
52 Weeks Range:16.921 - 27.32
52 Weeks Price Volatility (%):
15.00%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

DUSA Pharmaceuticals, Inc. (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company's marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp. During the year ended December 31, 2011, it initiated an exploratory DUSA-sponsored clinical trial designed to study the broad area application and/or short drug incubation (BASDI), method of using the Levulan Kerastick, which is being carried out at 10 clinical trial sites. DUSA manufactures its Levulan Kerastick in its Wilmington, Massachusetts facility. Its wholly owned subsidiaries include DUSA Pharmaceuticals New York, Inc. and Sirius Laboratories, Inc. As of December 31, 2011, DUSA ceased marketing and selling its remaining Non-PDT products, which were ClindaReach and Meted.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2005  6240  435  203 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SPY 246.15-11.60 
 CCL 8.80-4.37 
 DFFN 0.51+0.193 
 F 4.40-0.43 
 USO 4.38+0.17 
 GE 7.04-0.90 
 AMRN 4.98+0.98 
 AMD 43.66-1.82 
 SQQQ 21.95+2.49 
 UWT 0.166+0.003 
Partners & Brokers